APA (7th ed.) Citation

Volkow, P., Chavez Galan, L., Ramon-Luing, L., Cruz-Velazquez, J., Cornejo-Juarez, P., Sada-Ovalle, I., . . . Islas-Muñoz, B. (2023). Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial. PLoS ONE, 18(5), 1. https://doi.org/10.1371/journal.pone.0280209

Chicago Style (17th ed.) Citation

Volkow, Patricia, Leslie Chavez Galan, Lucero Ramon-Luing, Judith Cruz-Velazquez, Patricia Cornejo-Juarez, Isabel Sada-Ovalle, Rogelio Perez-Padilla, and Beda Islas-Muñoz. "Impact of Valganciclovir Therapy on Severe IRIS-Kaposi Sarcoma Mortality: An Open-label, Parallel, Randomized Controlled Trial." PLoS ONE 18, no. 5 (2023): 1. https://doi.org/10.1371/journal.pone.0280209.

MLA (9th ed.) Citation

Volkow, Patricia, et al. "Impact of Valganciclovir Therapy on Severe IRIS-Kaposi Sarcoma Mortality: An Open-label, Parallel, Randomized Controlled Trial." PLoS ONE, vol. 18, no. 5, 2023, p. 1, https://doi.org/10.1371/journal.pone.0280209.